APA

Bronstein M., Musolino N., Jallad R., Cendros J. M., Ramis J., Obach R., Leselbaum A. & Catus F. (20060209). Pharmacokinetic profile of lanreotide Autogel in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days. : Clinical endocrinology.

Chicago

Bronstein M, Musolino N, Jallad R, Cendros J M, Ramis J, Obach R, Leselbaum A and Catus F. 20060209. Pharmacokinetic profile of lanreotide Autogel in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days. : Clinical endocrinology.

Harvard

Bronstein M., Musolino N., Jallad R., Cendros J. M., Ramis J., Obach R., Leselbaum A. and Catus F. (20060209). Pharmacokinetic profile of lanreotide Autogel in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days. : Clinical endocrinology.

MLA

Bronstein M, Musolino N, Jallad R, Cendros J M, Ramis J, Obach R, Leselbaum A and Catus F. Pharmacokinetic profile of lanreotide Autogel in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days. : Clinical endocrinology. 20060209.